Opgen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to combat infectious disease outbreaks. Their innovative products enable accurate and rapid detection, characterization, and tracking of pathogens to improve patient outcomes and public health. With a focus on antimicrobial resistance and biothreat detection, Opgen is dedicated to advancing the field of genomics in infectious disease management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#50 in Gaithersburg, MD

#449 in Maryland

#32,588 in US

Gaithersburg, MD, United States of America

Opgen, Inc.

Forward Citations = 3

12 inventors:

Adam Michael Briska (4 out of 4 patents)

George Terrance Walker (2 out of 2 patents)

Alex Saeed (2 out of 2 patents)

4. Vadim Sapiro (2 out of 2 patents)

5. Emily B Zentz (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Opgen, Inc.. Retrieved from https://idiyas.com/company/opgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]